Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Great Comebacks® Program Recognizes National Award Winners

June 5, 2011 8:32 am | by Bio-Medicine.Org | News | Comments

NEW ORLEANS, June 5, 2011 /- Chuck Wielgus, Executive Director of USA Swimming, was named this year's Great Comebacks® National Award recipient at a ceremony held in conjunction with the Wound, Ostomy and Continence Nurses (WOCN) Society's 43rd Annual Conference in New Orleans, LA....

NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil®

June 5, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

CHICAGO, June 5, 2011 /- Nektar Therapeutics (Nasdaq: NKTR ) today announced positive results from a subpopulation of patients in a Phase 2 clinical study evaluating single-agent NKTR-102 in women with platinum-resistant/refractory ovarian cancer.  A total of 33 women in the study...

New Study Released Today Showed Patients With Deadly Form of Lung Cancer Lived Longer Without Disease Worsening

June 5, 2011 5:31 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, June 5, 2011 /- Eli Lilly and Company (NYSE: LLY ) announced today that PARAMOUNT, its Phase III study evaluating ALIMTA® (pemetrexed for injection) in the continuation maintenance setting, met its primary endpoint of progression-free survival, or the time a patient is...

Advertisement

Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims

June 4, 2011 1:32 pm | by Bio-Medicine.Org | News | Comments

SWIFTWATER, Pa., June 4, 2011 /- Four-time NASCAR Cup Series champion Jeff Gordon, known as much for his prowess on the track as he is for his philanthropic activities and tireless support of critically ill children, has pledged his support of the Alabama tornado relief effort through the...

NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meetin...

June 4, 2011 11:34 am | by Bio-Medicine.Org | News | Comments

CHICAGO and SAN FRANCISCO, June 4, 2011 /- Nektar Therapeutics (Nasdaq: NKTR ) today announced positive results from a Phase 2 clinical study evaluating single-agent NKTR-102 as a second- and third-line treatment in patients with metastatic breast cancer during the 2011 American Society...

Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting

June 4, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

CHICAGO, June 4, 2011 /- Genomic Health, Inc. (Nasdaq: GHDX ) today announced results of ten studies being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, including a second large validation study confirming the performance of the Onco type DX® colon...

Study Finds Treatment with Metreleptin Improved Diabetes and Lipid Control in Patients with Partial Lipodystrophy

June 4, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, June 4, 2011 /- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today announced results from a study that showed treatment with metreleptin, an investigational treatment that is an analog of the human hormone leptin, improved diabetes and lipid control in patients with partial...

Shenzhen Wuzhou Changlian International Trading Co. Announces Arrival of New Infrared Thermometer Series

June 3, 2011 2:33 pm | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, June 3, 2011 /PRNewswire-Asia/ -- After 3 months of customer opinion surveys at home and abroad, and with great efforts between Shenzhen Wuzhou Changlian International Trading Co. and their partner's technology support, the company has just introduced a brand new series...

Advertisement

Faculty Selected to the American Academy of Nursing

June 3, 2011 1:32 pm | by Arizona State University | News | Comments

Five faculty selected for highest honor in nursing profession.read more

Oregon Homecare Providers Support Congressional Bill to Repeal Misguided Medicare Bidding Program

June 3, 2011 12:33 pm | by Bio-Medicine.Org | News | Comments

PORTLAND, Ore., June 3, 2011 /PRNewswire-USNewswire/ -- Providers of home medical equipment and services (HME) in Oregon support H.R. 1041, a bipartisan bill in Congress that would repeal the controversial Medicare "competitive" bidding program for certain medically required equipment and...

Quest Diagnostics to Speak at the Jefferies 2011 Global Healthcare Conference

June 3, 2011 11:32 am | by Bio-Medicine.Org | News | Comments

MADISON, N.J., June 3, 2011 /- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Jefferies 2011 Global Healthcare Conference in New York City. The presentation is...

Aidapak Services Repackaged Pharmaceuticals: Recall - Potential Cross Contamination with Beta Lactam Products

June 3, 2011 10:30 am | by U.S. Food & Drug Administration | News | Comments

Potential for serious anaphylactic reaction in patients with known hypersensitivity to beta-lactam or penicillin products.

Pioneer Surgical Awarded HealthTrust Contract for Spinal Implants

June 3, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

MARQUETTE, Mich., June 3, 2011 /- HealthTrust Purchasing Group, L.P., (HealthTrust) has awarded Pioneer Surgical Technology, Inc. (Pioneer Surgical) a spine implant agreement, beginning June 1, 2011. "We are very pleased to be a part of HealthTrust's new spine implant agreement. Our...

Advertisement

Everist Genomics Announces New Data on OncoDefenderâ„¢- CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients

June 3, 2011 6:37 am | by Bio-Medicine.Org | News | Comments

CHICAGO, and ANN ARBOR, Mich., June 3, 2011 /- Everist Genomics today announced updated results from a study of its OncoDefender-CRC assay, a molecular prognostic test for early-stage colorectal cancer patients, will be presented at the 2011 American Society of Clinical Oncology (ASCO)...

Wake Forest Baptist Medical Center and Cornerstone Pharmaceuticals Present Interim Data From Phase I Trial of CPI-613 in Acute Myeloid Leukemia

June 3, 2011 6:36 am | by Bio-Medicine.Org | News | Comments

CHICAGO, June 3, 2011 /- Cornerstone Pharmaceuticals and Wake Forest Baptist Medical Center today announced key findings from a Phase I clinical trial of Cornerstone's first-in-class cancer metabolism inhibitor drug, CPI-613 in Acute Myeloid Leukemia (AML). Data will be presented at the...

U.S., Canadian Hospitals' Stroke Imaging -- and Results -- Differ

June 3, 2011 6:33 am | by Diagnostic Imaging | News | Comments

The study's focus was on the use of CT, MRI, ultrasound and x-ray imaging given the American hospital's far greater capacity of scanners.

Perma-Fix Signs Option Agreement to License Technology for Use in Proprietary Process to Produce Medical Isotopes

June 3, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

ATLANTA, June 3, 2011 /- Perma-Fix Environmental Services, Inc. (NASDAQ: PESI ) today announced it has signed an exclusive option agreement with Battelle, which operates Pacific Northwest National Laboratory for the U.S. Department of Energy, to license technology from PNNL for use with...

Siemens Expands Customer Return on Innovation at SNM 2011

June 3, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

SAN ANTONIO, June 3, 2011 /- At the 2011 SNM Annual Meeting in San Antonio, Siemens Healthcare (booth #6033) will address the increasing demand for molecular imaging procedures and Siemens' efforts to expand molecular imaging's availability in three directions: patient access, clinical...

Patient Advocate Foundation Announces Additional Support for Patient Co-Pay Relief Program Serving Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Patients

June 3, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

HAMPTON, Va., June 3, 2011/PRNewswire-USNewswire/ -- Patient Advocate Foundation (PAF) is pleased to announce that it has received a new contribution enabling it to begin offering support to patients suffering with nonsquamous non-small cell lung cancer (NSCLC) through its Co-Pay Relief...

Summary Information for: XIENCE nano? Everolimus Eluting Coronary Stent System

June 3, 2011 6:30 am | by U.S. Food & Drug Administration | News | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for XIENCE nano? Everolimus Eluting Coronary Stent System (P070015S054).

Rigel to Present at Jefferies Global Healthcare Conference

June 3, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

SOUTH SAN FRANCISCO, June 3, 2011 /- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to present a company overview at the Jefferies 2011 Global Healthcare Conference in New York City on...

TPI Board Reinstates Stock Repurchase Program

June 3, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

CHENGDU, China, June 3, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI ), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals today...

CIO magazine Honors Life Technologies for Leadership in Information Technology

June 3, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., June 3, 2011 /- Life Technologies Corporation (NASDAQ: LIFE ) has been honored by IDG's CIO magazine as a part of the 2011 CIO 100 , an annual award program that recognizes organizations around the world that exemplify the highest level of operational and strategic...

DURECT to Present at the Jefferies Healthcare Conference

June 3, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

CUPERTINO, Calif., June 3, 2011 /- DURECT Corporation (Nasdaq: DRRX ) announced today that Jim Brown, President and CEO, will be presenting at the Jefferies Healthcare Conference on Tuesday, June 7 at 4:30 p.m. Eastern time.  The conference is being held at the Grand Hyatt in New...

Echo Therapeutics to Present at the Jefferies 2011 Global Healthcare Conference

June 3, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

PHILADELPHIA, June 3, 2011 /- Echo Therapeutics, Inc. (OTCBB: ECTE), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug delivery, today...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading